Total Funding
66
59
Total FundingFunding Round raised
Growth Score
-4 pts
Heat Score
-1 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
82337
Sea Pharmaceuticals specializes in the development of new oral molecules for the treatment of tinnitus and epilepsy.
- James Pearson: President, CEO, Chief Science Officer (CSO), Founder, and Director
About the Company
Sea Pharmaceuticals is a neurotherapeutics company specializing in the development of new oral molecules for the treatment of tinnitus and epilepsy. The company invents, discovers, and advances research & development (R&D), and plans to commercialize Sea's own novel proprietary synthetic small molecules as innovative treatments for
Tinnitus, Epilepsy, and other high medical need therapeutic neurology indications including genetic disorders of the CNS.
